Dixon Robert L JR 4
Research Summary
AI-generated summary
Elevance Health (ELV) Director Robert L. Dixon Jr. Sells 151 Shares
What Happened
Robert L. Dixon Jr., a director of Elevance Health (ELV), reported an open-market sale of 151 shares on 2026-06-11 at $401.77 per share, producing proceeds of approximately $60,667. This was a disposal (sale) rather than a purchase.
Key Details
- Transaction date: 2026-06-11
- Transaction type/code: Open-market sale (S)
- Shares sold: 151 at $401.77 each; proceeds ≈ $60,667
- Form filed: accession 0001524849-26-000004, filed 2026-06-12 (timely; within two business days)
- Shares owned after transaction: not provided in the information supplied — check the full Form 4 for "Amount Owned" if needed
- Footnotes/plan: no 10b5-1 plan, tax-withholding, or other special footnotes reported in the supplied data
Context
Insider sales are common and can reflect many personal or tax-related reasons; they do not by themselves indicate the company’s outlook. Purchases generally carry clearer bullish signals for investors. For full details, review the Form 4 filing (accession 0001524849-26-000004) on the SEC EDGAR site.